ENHANCING PATIENTS' LIVES THROUGH INNOVATIVE AND EVIDENCE-BASED MEDICAL POSSIBILITIES VIA OUR THREE(3) BUSINESS UNITS.
Driven by our mission to enhance lives through pharmaceuticals and medical products, we continuously strive to explore and provide clinically proven medical possibilities to address unmet medical needs.
We keep abreast of the latest developments in the medical fields through our Disease Management Ecosystem, reinforcing our collaboration with key opinion leaders, various governmental, private and medical professional bodies through Amet Acies.
Our board of directors sets the strategic directions and long-term goals to scale the business for EP Plus Group’s sustainable growth.
Driven by our mission to enhance lives through pharmaceuticals and medical products, we continuously strive to explore and provide clinically proven medical possibilities to address unmet medical needs.
We keep abreast of the latest developments in the medical fields through our Disease Management Ecosystem, reinforcing our collaboration with key opinion leaders, various governmental, private and medical professional bodies through Amet Acies.
OUR STRATEGIC BUSINESS UNITS
We constantly source for advanced medical possibilities to improve patients’ lives through our strategic business units.
PHARMA-
CEUTICALS
ADDRESSING UNMET MEDICAL NEEDS
FERTILITY
SCIENCES
FULFILLING DREAMS OF PARENTHOOD
MEDICAL
AESTHETICS
THE SCIENCE OF BEAUTY
OUR PATIENTS' HEALTH AND SAFETY IS OF UTMOST IMPORTANCE
OFFERING EVIDENCE-BASED PRODUCTS, APPROVED BY VARIOUS HEALTH AUTHORITIES.
We do not compromise on health and safety as part of our unwavering commitment to improve the lives of our patients.
Our products are sourced from R&D-based reputable healthcare companies with a long history of providing evidence-based, innovative pharmaceuticals and medical products benefiting patients worldwide.
Our Regulatory Affairs and Quality Assurance Department is responsible for protecting and ensuring the quality of our products.
– National Pharmaceutical Regulatory Agency (NPRA)
– Medical Device Authority (MDA)
– Health Sciences Authority (HSA)
– National Agency of Drug and Food Control (BPOM)
DEDICATED & SPECIALISED COMMERCIAL TEAM
TO SERVE OUR PARTNERS AND CUSTOMERS BETTER.
Our commercial teams are organised based on therapeutic class and skills specialisation.
This ensures efficiency and effectiveness in our execution and are able to provide knowledge related to our customers’ field of practice or interest.
CONSTANT SOURCING TO DRIVE PORTFOLIO GROWTH
We actively source innovative, clinically proven products across pharmaceuticals, medical devices, and consumer healthcare. These products complement our existing range and support disease management across key therapeutic areas.
Our Business Development team scans global markets to identify opportunities that align with our commercial strategy and respond to real treatment needs. Every product we bring in is carefully selected for its potential to improve patient outcomes and fill gaps in care.
This continuous expansion fuels our growth and strengthens our position in the region. It also enables our Commercial team to deliver end-to-end go-to-market execution, from product registration and launch to demand generation and channel engagement.
This is how we work towards our ambition of becoming the Leading Healthcare Group in Southeast Asia.
THERAPEUTIC AREAS
We focus on managing care related to the following areas.